Stock data
Aurinia Pharmaceuticals Inc (AUPH)
Aurinia Pharmaceuticals Inc (AUPH) reported revenue of US$283.06M and net income of US$287.20M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$283.06M | — | US$104.91M | US$287.20M | — |
| 2024 | US$235.13M | — | -US$4.69M | US$5.75M | — |
| 2023 | US$175.51M | — | -US$91.69M | -US$78.02M | — |
| 2022 | US$134.03M | — | -US$111.47M | -US$108.18M | — |
| 2021 | US$45.60M | — | -US$180.74M | -US$180.97M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$83.22M | US$37.41M | — |
| 2026-03-31 | US$77.70M | US$34.35M | — |
| 2025-12-31 | US$77.11M | US$210.79M | — |
| 2025-09-30 | US$73.47M | US$31.55M | — |
| 2025-06-30 | US$70.01M | US$21.51M | — |
| 2025-03-31 | US$62.47M | US$23.34M | — |
| 2024-12-31 | US$59.87M | US$1.43M | — |
| 2024-09-30 | US$67.77M | US$14.35M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.